Answers are grounded in this paper and cite their sources.
Reports rare rupture of unruptured intracranial aneurysms following intravenous thrombolysis in acute ischemic stroke, indicating potential safety.
Background: An incidental finding of unruptured aneurysm, which is a contraindication to the recombinant tissue plasminogen activator (rtPA), is common in patients with acute ischemic strokes. However, reports describing the rupture of intracranial aneurysm following the administration of rtPA are extremely rare.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: